Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
M. von Herrath, S. Bain, B. Bode, J. Clausen +109 more
2021The Lancet Diabetes and Endocrinology145 citations Open access
Semantic Scholar